Franklin Resources’s Alto Neuroscience ANRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26.7M Sell
1,013,307
-88,567
-8% -$2.05M 0.01% 911
2026
Q1
$24.8M Sell
1,101,874
-17,704
-2% -$328K 0.01% 904
2025
Q4
$19.9M Sell
1,119,578
-43,030
-4% -$542K ﹤0.01% 957
2025
Q3
$4.67M Hold
1,162,608
﹤0.01% 1442
2025
Q2
$2.56M Hold
1,162,608
﹤0.01% 1630
2025
Q1
$2.51M Hold
1,162,608
﹤0.01% 1606
2024
Q4
$4.92M Sell
1,162,608
-58,104
-5% -$363K ﹤0.01% 1353
2024
Q3
$17M Buy
1,220,712
+595,673
+95% +$7.29M ﹤0.01% 946
2024
Q2
$6.68M Buy
625,039
+27
+0% +$351 ﹤0.01% 1215
2024
Q1
$9.59M Buy
+625,012
New +$9.78M ﹤0.01% 1091

Other funds holding ANRO

Franklin Resources's ANRO Position: Q2 2026 in Review

Franklin Resources reduced its Alto Neuroscience (ANRO) stake by 8% in Q2 2026, selling an estimated $2.05M and leaving 1,013,307 shares worth $26.7M. The position accounts for 0.01% of the portfolio, ranked #911.

Franklin Resources first reported a position in ANRO in Q1 2024 and has held it in 10 quarters since. 114 funds tracked by Wall St. Rank hold ANRO as of Q2 2026.

  • Franklin Resources held 1,013,307 shares of Alto Neuroscience worth $26.7M as of Q2 2026.
  • Franklin Resources sold 88,567 Alto Neuroscience shares in Q2 2026, an estimated $2.05M.
  • Alto Neuroscience made up 0.01% of Franklin Resources's portfolio in Q2 2026, its #911 holding.
  • Franklin Resources first reported a position in Alto Neuroscience in Q1 2024 and has held it in 10 quarters since.
  • 114 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.